STAT

STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and more

STAT+: Pharmalittle: We’re reading about an AstraZeneca setback, falling U.S. drug prices, and moreWorldPing

AstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run of setbacks…

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

The Verge

It’s about ethics in journalism, with Ben Smith

Today I’m talking to Ben Smith, the editor-in-chief of Semafor. Everywhere you go, people say they don’t trust the media — and yet they’ve never consumed more of it.

Brief by WorldPing · Original reporting by The Verge